Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
Medable
Provides a decentralized clinical trial platform to improve patient enrollment and retention.
What they do
Medable provides a cloud-based platform for decentralized and hybrid clinical trials. The software enables remote consent, electronic clinical outcome assessments, and telemedicine visits, allowing life sciences companies to recruit and retain diverse patient populations globally.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Decentralised trials
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Palo Alto, USA
- Region
- North America
- Founded
- 2015
- Total funding
- $504M raised
Notable investors: GSR Ventures, Tiger Global Management, Blackstone Group, Sapphire Ventures.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Pig Kidney Transplants Are Now in Human Trials. Here Is What EXPAND and Its Rivals Actually Have to Prove
Dr. Dereck Mush, MD, MBA
Inside SURPASS: ARPA-H's Bid to Redesign Clinical Trials
Dr. Dereck Mush, MD, MBA
Unlocking Orphan Neuromuscular Indications: Why IntraBio's Aqneursa Approval Signals a Regulatory Re-evaluation of Small-Cohort Crossover Trials
Dr. Dereck Mush, MD, MBA